COGNICURRENT

There is a rising demand for Lenacapavir, a new injectable medication for HIV prevention, as Nigeria prepares for its nationwide rollout.

A 23-year-old man in Ribeirão Preto, Brazil, reported being publicly humiliated by health professionals after his HIV-positive status was announced out loud, despite laws guaranteeing patient confidentiality.

Nigeria has received its first batch of 11,520 doses of Lenacapavir, an injectable drug for HIV prevention, donated by the Global Fund.

The U.S. government has presented Zambia with an ultimatum requiring drug provision for HIV in exchange for access to mineral resources.

A 23-year-old patient alleges that his positive HIV test was publicly announced by medical staff at a hospital in Ribeirão Preto, Brazil, leading to a complaint being filed with the police and the suspension of a nursing technician.

A new study suggests that a single daily pill combining two antiviral drugs could effectively simplify HIV treatment regimens, potentially improving adherence, especially among older patients or those with multiple health conditions.

The USA is considering reducing HIV aid to Zambia to pressure the country into a deal that would allow American companies greater access to its critical resources, as revealed by a draft memorandum from the US State Department.

A 23-year-old patient reported being publicly exposed and humiliated after his HIV positive test was announced loudly by healthcare professionals at a health unit in Brazil.

A patient in Ribeirão Preto, Brazil, expressed distress after his HIV positive test result was publicly declared at a healthcare facility, leading to feelings of humiliation and violation of privacy.

A 24-year-old man allegedly injected his HIV-infected blood into his 22-year-old fiancée after their wedding was called off due to his health condition.

A patient in Brazil has accused health professionals of loudly announcing their HIV positive diagnosis, prompting legal and administrative actions regarding privacy violations.

Health experts in Nigeria have raised alarms about the increasing number of Advanced HIV Disease cases among children and adolescents, attributing this trend to stigma, lack of awareness, and inadequate access to diagnostic resources.

A 23-year-old patient reported being humiliated after his positive HIV test was announced loudly by health professionals at a UPA in Ribeirão Preto, SP.

A couple in Bologna is under investigation for aggravated maltreatment of their daughter, who contracted severe infections and Aids due to the parents' negligence regarding her health care.

A recent report highlights alarming gaps in awareness, diagnosis, and treatment of Advanced HIV Disease among children and adolescents in several Nigerian states, exacerbated by stigma and resource limitations.

The parents of an HIV-positive girl are facing trial for allegedly neglecting her medical care, revealed when she was taken to a pediatrician at the age of six, weighing less than ten kilograms.

An AI-powered X-ray system has been introduced in Campo Grande to assist in the quick detection of multiple diseases in individuals living with HIV.

Two parents in Bologna are on trial for aggravated mistreatment after failing to provide necessary vaccinations and medical treatment for their HIV-positive daughter.

Nigeria has received its first shipment of the long-acting injectable drug Lenacapavir for HIV prevention, aimed at expanding the country’s prevention options.

A mother is on trial for transmitting HIV to her daughter and neglecting her medical care, leading to severe health deteriorations.

Two parents are on trial in Bologna for neglecting their daughter, who was born with HIV, leading to serious health complications.

The Quito Municipality has launched a campaign providing free Pap smears and HIV tests to designated neighborhoods in the city.

Health professionals are embarking on a boat to provide free medical consultations, vaccinations, and rapid HIV, syphilis, and hepatitis testing to residents of 150 isolated rural communities around Rio Branco, Brazil.

Ecuador's Ministry of Public Health reports a combined prevention strategy for HIV, featuring pre-exposure prophylaxis (PrEP), has successfully reached 12,897 users in its implementation since 2023.

South Africa's National Aids Council is soliciting local drug companies to apply for the creation of generic versions of the anti-HIV jab lenacapavir, targeting a goal to end AIDS in the country by 2043.

South Africa aims to locally produce Lenacapavir, a revolutionary preventive treatment for HIV, which has just begun to be administered on the continent.

Thousands of Americans are losing access to HIV treatment as nearly 20 states impose restrictions on assistance programs.

Families of victims of the infected blood scandal have criticized the UK government for creating a compensation scheme that penalizes them for the deaths of their loved ones.

South Africa is aiming to produce the HIV prevention drug lenacapavir locally to enhance treatment access and support its pharmaceutical sector.

NAFDAC has issued a warning about counterfeit HIV test kits circulating in Nigeria, urging the public and healthcare providers to be vigilant.

The Nigerian Federal Executive Council has approved N9.99 billion for the procurement of HIV antiretroviral drugs and the upgrade of cancer treatment facilities.

NAFDAC has issued a safety alert regarding malaria and HIV test kits from Meril Diagnostics Pvt. Ltd due to significant violations found in an audit by the WHO.

The fight against HIV in Ukraine faces severe challenges due to the ongoing war, resulting in unreliable infection statistics and a potential undercounting of cases.

Nigeria is set to receive Lenacapavir, a significant HIV prevention injection, in March, which has shown 100% efficacy in clinical trials.

Municipal pharmacies in Piracicaba, Brazil are now providing free HIV self-testing, following a new initiative from the local health department.

Nigeria is set to receive a new HIV prevention injection called Lenacapavir in March 2026 as part of efforts to reduce new infections.

The International Zero Discrimination Day on March 1st highlights the ongoing fight against various forms of discrimination worldwide, initially focusing on HIV/AIDS-related stigma and now encompassing broader issues of inequality.

March 1 is recognized as Zero Discrimination Day, promoting awareness and rights for individuals living with HIV/AIDS, as proclaimed by the United Nations.

A new daily single-dose pill for HIV treatment, BIC/LEN, has shown promise in clinical trials, simplifying the lives of long-term HIV patients.

Bashir Lukonge, known as Bash Luks, is gaining prominence in Uganda's entertainment scene by blending music, film, and advocacy for HIV awareness.

Denmark has become the first country in the world to eliminate mother-to-child transmission of HIV and syphilis according to the World Health Organization.

Kenya has begun providing lenacapavir, a long-acting injectable HIV prevention drug, free of charge to eligible patients, marking a significant advancement in the fight against HIV.

A recent webinar addressed the ethical and scientific considerations in pediatric HIV cure research, highlighting the role of people living with HIV in this field.

The article emphasizes the importance of trust and clear communication in HIV cure research to combat misinformation and build community engagement in South Africa.

The article discusses the significance of involving people living with HIV in the research for a cure, particularly in children, amidst ongoing challenges and ethical considerations.

Kenya has launched the use of a new injectable preventive treatment against HIV called lenacapavir, marking a significant advance in HIV prevention methods.

A new once-daily HIV drug could simplify treatment for elderly patients who have been managing the virus for decades.

Eduardo Casanova shares his experience of living with HIV and the stigma associated with it while promoting his documentary 'Sidosa.'

Kenya has started administering LENACAPAVIR, a revolutionary long-acting HIV prevention drug, marking a significant step in the fight against HIV/AIDS.

A long-anticipated preventive HIV treatment, cabotegravir, is set to be available in France, fully covered by health insurance.